Pressure BioSciences, Inc. Stock price Nasdaq
Equities
US74112E1091
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Financials (USD)
Sales 2021 | 2M | Sales 2022 | 1.73M | Capitalization | 15.89M |
---|---|---|---|---|---|
Net income 2021 | -20M | Net income 2022 | -16M | EV / Sales 2021 | 16.4 x |
Net Debt 2021 | 14.51M | Net Debt 2022 | 20.53M | EV / Sales 2022 | 21.1 x |
P/E ratio 2021 |
-0.68
x | P/E ratio 2022 |
-0.81
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.94% |
Latest transcript on Pressure BioSciences, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 78-07-31 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 70 | 06-04-23 |
Chief Tech/Sci/R&D Officer | 59 | 06-04-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 78-07-31 | |
Vito Mangiardi
BRD | Director/Board Member | 75 | 12-07-02 |
Michael Urdea
BRD | Director/Board Member | 71 | 13-02-07 |
1st Jan change | Capi. | |
---|---|---|
+3.10% | 197B | |
+1.11% | 71.22B | |
+12.40% | 53.77B | |
+19.12% | 48.75B | |
+6.87% | 44.22B | |
+11.92% | 28.85B | |
+10.40% | 27.62B | |
+10.13% | 28.57B | |
+19.96% | 26.73B |
- Stock
- Equities
- Stock Pressure BioSciences, Inc.
- Stock Pressure BioSciences, Inc. - Nasdaq